WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Gangs in Haiti launch fresh attacks, days after a new prime minister is announcedBritney Spears reaches divorce settlement with estranged husband Sam AsghariMiddle school focuses on recovery as authorities investigate shooting of armed studentThe Rolling Stones are set to rock New Orleans Jazz Fest after two previous triesJurors hear closing arguments in landmark case alleging abuse at New Hampshire youth centerTurkey halts all trade with Israel over military actions in GazaMississippi high court declines to rule on questions of public funds going to private schoolsA committee finds a decayed and broken utility pole caused the largest wildfire in Texas historyGeorgia governor signs law adding regulations for production and sale of herbal supplement kratomAnswering readers' questions about the protest movement on US college campuses